Alphabet Inc.

GOOG

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 14,016Value: $4.4M

Driehaus Capital's new $4.4M Alphabet position likely reflects conviction in Google's AI/biotech initiatives (DeepMind's AlphaFold drug discovery platform, Isomorphic Labs pipeline) rather than core search/advertising fundamentals. The initiation suggests growth-focused investors see material value creation potential in Alphabet's life sciences applications over a multi-year horizon. Position size indicates modest conviction relative to fund AUM, consistent with a speculative allocation to biotech-adjacent tech exposure.

More GOOG Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: